Close Menu

NEW YORK (GenomeWeb) – NantHealth's third quarter revenues grew around 2 percent year over year, the company reported after the close of the market on Thursday.

The Culver City, California-based company said that it recorded $22.3 million in revenues for the three months ended Sept. 30, up from $21.8 million during Q3 2017. It missed the consensus Wall Street estimate of $24.6 million for the top line.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Mar
31
Sponsored by
Isoplexis

This webinar will discuss the application of single-cell proteomics and immune-imaging in adoptive cell therapy (ACT) for cancer.